Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US Rare Diseases A disease is considered rare when it affects no more than 5 people amongst 10,000 inhabitants. The low incidence of these diseases amongst the population, however, does not signify that few rare diseases exist. This in fact is a phenomena that affects millions of people in Italy alone, and tens of thousands throughout Europe. The number of rare diseases known and diagnosed to date is between 7,000 and 8,000. The market for drugs to cure each of these single diseases is so small that the pharmaceutical industry has so far been reluctant to invest in the research and discovery processes required to develop effective treatments. As a consequence, the majority of these diseases remain without treatments or a cure, opening up an enormous gap and the need for new therapies. Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners

Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US Research Areas Malaria Schistosomiasis Nematode infections Tuberculosis Hemoglobinopathies Muscular dystrophies Rare cancers Identification of new therapeutic targets Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners